A multi-centre randomised controlled trial of the efficacy and mechanism of action of gabapentin for the management of chronic pelvic pain in women (GaPP)

Project Details

Effective start/end date1/03/1531/10/19


  • UK central government bodies/local authorities, health and hospital authorities: £1,448,916.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.